Natriuretic peptide receptor B signaling in the cardiovascular system: protection from cardiac hypertrophy
about
Defective cellular trafficking of missense NPR-B mutants is the major mechanism underlying acromesomelic dysplasia-type MaroteauxNovel mutations in natriuretic peptide receptor-2 gene underlie acromesomelic dysplasia, type maroteaux.C-type natriuretic peptide slows down wound healing but promotes angiogenesis in SKH1-hr hairless mice.BNP molecular forms and processing by the cardiac serine protease corin.Discovery of novel small molecule inhibitors of cardiac hypertrophy using high throughput, high content imaging.Chronic C-Type Natriuretic Peptide Infusion Attenuates Angiotensin II-Induced Myocardial Superoxide Production and Cardiac Remodeling.Lebetin 2, a Snake Venom-Derived Natriuretic Peptide, Attenuates Acute Myocardial Ischemic Injury through the Modulation of Mitochondrial Permeability Transition Pore at the Time of Reperfusion.C-Type Natriuretic Peptide Improves Left Ventricular Functional Performance at Rest and Restores Normal Exercise Responses after Heart Failure.Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides.Comparative measurement of CNP and NT-proCNP in human blood samples: a methodological evaluationEarly improvement of symptoms using LCZ696 in a patient with systolic heart failure and a reduced ejection fraction: a case report.Acromesomelic dysplasia, type maroteaux caused by novel loss-of-function mutations of the NPR2 gene: Three case reports.
P2860
Q24655560-3FFC421B-D0B5-41C5-BBD1-C8DDB06F036EQ34301501-59755466-B692-4D67-BFDB-42B8F444758CQ34304206-DA0F2B1B-3581-4B78-B641-5D9E9E0C8B0FQ34369603-0A2B5BD3-E9E6-49DD-BD01-A28F41933585Q36003962-75D66E0A-971B-4E12-A7B4-CE0400AB0DD2Q36119104-E91ED3C3-8785-4DA7-98E4-02C8EA20963CQ36129944-584D6A2C-34C7-43F7-AA39-506DE5DF537BQ36947760-F3283432-59D7-4701-82FB-474512CA1EB4Q37914058-96FD5D44-EE7F-44E4-9562-D5D1BB8F8BD9Q39441683-E7E785C7-E1ED-46B5-A2C6-C4EC759065EFQ48620948-63CAED6B-18F1-45D4-BFB0-32CE72D8C7ECQ52902805-E0F4F207-7DA2-40AC-8934-EB4199C2541A
P2860
Natriuretic peptide receptor B signaling in the cardiovascular system: protection from cardiac hypertrophy
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Natriuretic peptide receptor B ...... ction from cardiac hypertrophy
@ast
Natriuretic peptide receptor B ...... ction from cardiac hypertrophy
@en
Natriuretic peptide receptor B ...... ction from cardiac hypertrophy
@nl
type
label
Natriuretic peptide receptor B ...... ction from cardiac hypertrophy
@ast
Natriuretic peptide receptor B ...... ction from cardiac hypertrophy
@en
Natriuretic peptide receptor B ...... ction from cardiac hypertrophy
@nl
prefLabel
Natriuretic peptide receptor B ...... ction from cardiac hypertrophy
@ast
Natriuretic peptide receptor B ...... ction from cardiac hypertrophy
@en
Natriuretic peptide receptor B ...... ction from cardiac hypertrophy
@nl
P2093
P2860
P3181
P1476
Natriuretic peptide receptor B ...... ction from cardiac hypertrophy
@en
P2093
Ines Pagel-Langenickel
Jens Buttgereit
Thomas H Langenickel
P2860
P2888
P304
P3181
P356
10.1007/S00109-007-0183-4
P407
P577
2007-08-01T00:00:00Z
P6179
1039932240